adagrasib,Pembrolizumab
mirati,merck
['pembro', 'mrtx849', 'solid tumor', 'nsclc', 'synergy', 'sclc', 'adagrasib', 'adaptive ']
we're looking for synergy with the two agents - more than an additive effect. reason to believe there will be based on preclinical data showing the effect on t-cell infiltration from #kras inhibition. similar to what has been shown with mek inhibition. #esmoimmuno22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Host Official @IASLC Podcast #LCSM #HereWeGo #ITYSL